Johnson & Johnson proposes to pay $6.5B to settle talc ovari

Johnson & Johnson proposes to pay $6.5B to settle talc ovarian cancer lawsuits in US

Through a bankruptcy filing of its subsidiary company, J&J will be able to resolve about 99.75% of the pending talc lawsuits against the company and its affiliates in the U.S.

Related Keywords

Michelle Parfitt , Corinne Le Goff , Leigh Odell , Johnson , Drug Administration , Leigho Dell ,

© 2025 Vimarsana